Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Nick Collins
Advertisement
EDC IT Product Lead, AstraZeneca
Articles by Nick Collins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
EDC IT Product Lead, AstraZeneca
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
